NCT00028860View on ClinicalTrials.gov

Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2001

Study Completion Date

October 31, 2004

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

gemcitabine hydrochloride

DRUG

ifosfamide

DRUG

paclitaxel

PROCEDURE

adjuvant therapy

Trial Locations (1)

70112

Tulane Cancer Center at Tulane University Hospital and Clinic, New Orleans

All Listed Sponsors
lead

Tulane University Health Sciences Center

OTHER

NCT00028860 - Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer | Biotech Hunter | Biotech Hunter